NEW YORK (GenomeWeb News) – Agilent today reported 17 percent year-over-year revenue growth in its Life Science business unit for its fourth fiscal quarter, driven by a 40 percent boost in microarray sales.
 
For the three months ended Oct. 31, 2008, revenues for Agilent’s Life Science business, a division of its Bio-Analytical Measurement unit, rose 17 percent to $276 million. Revenue growth for this business was 10 percent excluding acquisitions.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.